title: Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry.
abstract: OBJECTIVE
  To assess actual practices and in-hospital outcome of patients with acute myocardial infarction on a nationwide scale.
  
  
  METHODS
  Of 443 intensive care units in France, 369 (83%) prospectively collected data on all cases of infarction (within < 48 hours of symptom onset) in November 2000.
  
  
  RESULTS
  2320 patients (median age 68 years, 73% men) were included, of whom 83% had ST segment elevation infarction (STEMI). Patients without STEMI were older and had a more frequent history of cardiovascular disease. Median time to admission was 5.0 hours for patients with and 6.5 hours for those without STEMI. Reperfusion therapy was used for 53% of patients with STEMI (thrombolysis 28%, primary angioplasty 25%). In-hospital mortality was 8.7% (5.5% of patients without and 9.3% of those with STEMI). Multivariate analysis found that age, Killip class, lower blood pressure, higher heart rate on admission, anterior location of infarct, STEMI, diabetes mellitus, previous stroke, and no current smoking independently predicted in-hospital mortality. At hospital discharge, 95% received antiplatelet agents, 75% received beta blockers, and over 60% received statins. Angiotensin converting enzyme inhibitors were prescribed for 40% of the patients without and 52% of those with ST elevation.
  
  
  CONCLUSIONS
  This nationwide registry, including all types of centres irrespective of their size and experience, shows continued improvement in patient care and outcomes. Time from symptom onset to admission, however, has not improved in recent years and reperfusion therapy is used for just over 50% of patients with STEMI, with an increasing use of primary angioplasty.
authors.affiliation: CH Aulnay, France.
authors.forename: G
authors.initials: G
authors.lastname: Hanania
authors.forename: J-P
authors.initials: JP
authors.lastname: Cambou
authors.forename: P
authors.initials: P
authors.lastname: Guéret
authors.forename: L
authors.initials: L
authors.lastname: Vaur
authors.forename: D
authors.initials: D
authors.lastname: Blanchard
authors.forename: J-M
authors.initials: JM
authors.lastname: Lablanche
authors.forename: Y
authors.initials: Y
authors.lastname: Boutalbi
authors.forename: R
authors.initials: R
authors.lastname: Humbert
authors.forename: P
authors.initials: P
authors.lastname: Clerson
authors.forename: N
authors.initials: N
authors.lastname: Genès
authors.forename: N
authors.initials: N
authors.lastname: Danchin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D003422:Critical Care / Q000379:methods*; D005260:Female; D005602:France / Q000453:epidemiology; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality* / Q000628:therapy; D015425:Myocardial Reperfusion / Q000379:methods; D011446:Prospective Studies; D012042:Registries; D015912:Thrombolytic Therapy / Q000379:methods; D016896:Treatment Outcome